tryn: Thanks for your response. In a macro sense, the field of diagnostic medicine will change dramatically in the next few years as personalized medicine becomes an acceptable and cost-effective alternative to the way many testing regimes are set up today. Couple that with higher effectiveness and HDVY's patent-protected position in this field and we could very be sitting on a multi-hundred bagger. As I have suggested previously, this stock will be volatile because of its current lack of earnings offset by the potential to have huge earnings begin to roll in within 1-3 years and increase thereafter. To me, the biggest challenge is to avoid the temptation to sell and hope to get back in at a lower price because whenever I have tried to outsmart the market, the market usually wins.
Market Data 
Markets 
AI
